
Stephen E. Jones
Examiner (ID: 2262, Phone: (571)272-1762 , Office: P/2842 )
| Most Active Art Unit | 2817 |
| Art Unit(s) | 2843, 2842, 2817 |
| Total Applications | 2057 |
| Issued Applications | 1739 |
| Pending Applications | 89 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17088569
[patent_doc_number] => 11116737
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-09-14
[patent_title] => Methods of using probenecid for treatment of coronavirus infections
[patent_app_type] => utility
[patent_app_number] => 16/875487
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13925
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875487 | Methods of using probenecid for treatment of coronavirus infections | May 14, 2020 | Issued |
Array
(
[id] => 17227125
[patent_doc_number] => 20210353681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => USE OF TNKS INHIBITORS FOR REGENERATION OF CARTILAGE
[patent_app_type] => utility
[patent_app_number] => 15/930940
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930940
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930940 | USE OF TNKS INHIBITORS FOR REGENERATION OF CARTILAGE | May 12, 2020 | Pending |
Array
(
[id] => 17685768
[patent_doc_number] => 20220193060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Inhibition of IL-1 Induced Inflammation
[patent_app_type] => utility
[patent_app_number] => 17/605447
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605447 | Inhibition of IL-1 Induced Inflammation | Apr 30, 2020 | Abandoned |
Array
(
[id] => 17685729
[patent_doc_number] => 20220193021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMBINATION THERAPY FOR TREATING INFLUENZA VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/608452
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17608452
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/608452 | COMBINATION THERAPY FOR TREATING INFLUENZA VIRUS INFECTION | Apr 29, 2020 | Pending |
Array
(
[id] => 18589153
[patent_doc_number] => 11738025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Method for treating coronavirus infections
[patent_app_type] => utility
[patent_app_number] => 16/851047
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 30
[patent_no_of_words] => 17795
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851047 | Method for treating coronavirus infections | Apr 15, 2020 | Issued |
Array
(
[id] => 17735021
[patent_doc_number] => 20220220480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF NLRP3 INFLAMMASOME MEDIATED IL-1BETA DEPENDENT DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/603997
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17603997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/603997 | METHODS AND COMPOSITIONS FOR TREATMENT OF NLRP3 INFLAMMASOME MEDIATED IL-1BETA DEPENDENT DISORDERS | Apr 15, 2020 | Pending |
Array
(
[id] => 16296344
[patent_doc_number] => 20200282067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => THERAPEUTIC COMPOSITIONS OF DECANOIC ACID AND ARGININE
[patent_app_type] => utility
[patent_app_number] => 16/836893
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27560
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16836893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/836893 | Therapeutic compositions of decanoic acid and arginine | Mar 30, 2020 | Issued |
Array
(
[id] => 16153699
[patent_doc_number] => 20200215082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 16/823411
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823411 | Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of Cancer | Mar 18, 2020 | Abandoned |
Array
(
[id] => 17655386
[patent_doc_number] => 20220175851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/437643
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437643
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437643 | COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH | Mar 12, 2020 | Pending |
Array
(
[id] => 17805769
[patent_doc_number] => 20220257604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS AND METHODS FOR MODULATING VIRAL INFECTIONS BY REGULATING GLUCOSYLCERAMIDES
[patent_app_type] => utility
[patent_app_number] => 17/437010
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437010 | COMPOSITIONS AND METHODS FOR MODULATING VIRAL INFECTIONS BY REGULATING GLUCOSYLCERAMIDES | Mar 8, 2020 | Abandoned |
Array
(
[id] => 16108397
[patent_doc_number] => 20200206221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/811728
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811728
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811728 | BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | Mar 5, 2020 | Abandoned |
Array
(
[id] => 17503319
[patent_doc_number] => 20220096421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => Active Ingredient, Pharmaceutical Composition, and Medicinal Product for HIV and AIDS Therapy
[patent_app_type] => utility
[patent_app_number] => 17/418249
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418249
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418249 | Active Ingredient, Pharmaceutical Composition, and Medicinal Product for HIV and AIDS Therapy | Mar 4, 2020 | Abandoned |
Array
(
[id] => 18353963
[patent_doc_number] => 11642347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => EZH2 inhibitors for treating lymphoma
[patent_app_type] => utility
[patent_app_number] => 16/808513
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12951
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808513 | EZH2 inhibitors for treating lymphoma | Mar 3, 2020 | Issued |
Array
(
[id] => 16086633
[patent_doc_number] => 20200197303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => PERIODONTIC TREATMENT AND METHOD
[patent_app_type] => utility
[patent_app_number] => 16/804178
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804178
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/804178 | Periodontic treatment and method | Feb 27, 2020 | Issued |
Array
(
[id] => 18273687
[patent_doc_number] => 11612608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Methods of treating oral mucositis
[patent_app_type] => utility
[patent_app_number] => 16/802916
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 25158
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 551
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16802916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/802916 | Methods of treating oral mucositis | Feb 26, 2020 | Issued |
Array
(
[id] => 16581416
[patent_doc_number] => 20210015818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => METHODS OF TREATING LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/803824
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16803824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/803824 | Methods of treating liver disease | Feb 26, 2020 | Issued |
Array
(
[id] => 17609680
[patent_doc_number] => 20220151959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHOD FOR TREATING ALLERGIC SKIN DISEASE OR PRURITUS CUTANEOUS
[patent_app_type] => utility
[patent_app_number] => 17/433829
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433829 | METHOD FOR TREATING ALLERGIC SKIN DISEASE OR PRURITUS CUTANEOUS | Feb 23, 2020 | Pending |
Array
(
[id] => 16053325
[patent_doc_number] => 20200188517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => PHARMACEUTICAL CREAM COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/798176
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798176
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798176 | PHARMACEUTICAL CREAM COMPOSITIONS AND METHODS OF USE | Feb 20, 2020 | Abandoned |
Array
(
[id] => 16569073
[patent_doc_number] => 20210008079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => TREATMENT FOR DRY EYE
[patent_app_type] => utility
[patent_app_number] => 16/793581
[patent_app_country] => US
[patent_app_date] => 2020-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16793581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/793581 | TREATMENT FOR DRY EYE | Feb 17, 2020 | Abandoned |
Array
(
[id] => 17334487
[patent_doc_number] => 20220000818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => COMPOSITIONS FOR USE IN PREVENTING ACNE
[patent_app_type] => utility
[patent_app_number] => 17/425648
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425648 | COMPOSITIONS FOR USE IN PREVENTING ACNE | Jan 23, 2020 | Abandoned |